BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18434304)

  • 1. Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.
    Gardner AA; Reichert EC; Topham MK; Stafforini DM
    J Biol Chem; 2008 Jun; 283(25):17099-106. PubMed ID: 18434304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
    Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation.
    MacRitchie AN; Gardner AA; Prescott SM; Stafforini DM
    FASEB J; 2007 Apr; 21(4):1164-76. PubMed ID: 17210780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
    Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
    J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
    Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
    J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
    Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
    J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M; Tselepis AD
    Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).
    Stafforini DM
    Cardiovasc Drugs Ther; 2009 Feb; 23(1):73-83. PubMed ID: 18949548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto A; Saitta C; Bitto A; Castaldo M; Cinquegrani M; Bonaiuto M; Cristadoro S; Saitta A
    Aging Clin Exp Res; 2008 Apr; 20(2):171-7. PubMed ID: 18431085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL.
    Tselepis AD; Karabina SA; Stengel D; PiƩdagnel R; Chapman MJ; Ninio E
    J Lipid Res; 2001 Oct; 42(10):1645-54. PubMed ID: 11590221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
    Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
    Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
    Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.
    Wu X; McIntyre TM; Zimmerman GA; Prescott SM; Stafforini DM
    Biochem J; 2003 Oct; 375(Pt 2):351-63. PubMed ID: 12854969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
    Tsimihodimos V; Kakafika A; Tambaki AP; Bairaktari E; Chapman MJ; Elisaf M; Tselepis AD
    J Lipid Res; 2003 May; 44(5):927-34. PubMed ID: 12611907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor acetylhydrolase.
    Arai H
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():83-94. PubMed ID: 12432911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.